基于治疗后早期反射共聚焦显微镜特征无创预测面部特应性皮炎度普利尤单抗应答
结果显示第4周真皮乳头扩张与乳头毛细血管迂曲扩张与治疗无应答显著相关,基于ResNet101的模型测试AUC为0.796。
要点
- 第4周RCM示真皮乳头扩张与毛细血管迂曲扩张提示度普利尤单抗可能无应答
- 基于第4周RCM图像的ResNet101深度学习模型测试AUC为0.796
- 早期RCM联合深度学习可作为面部AD疗效的无创预测辅助手段
核心结论
- 治疗后早期RCM特征联合深度学习可有效预测度普利尤单抗对面部AD皮损的疗效。
研究设计与样本
- 按第16周EASI较基线改善75%分为应答组与非应答组
- 使用RCM评估面部皮损,并采用深度学习构建组间差异识别预测模型
主要发现
- 第4周真皮乳头扩张与治疗无应答显著相关,AUC为0.83,P < .001
- 第4周迂曲乳头毛细血管扩张与治疗无应答显著相关,AUC为0.81,P < .001
- 基于第4周治疗后RCM图像训练的ResNet101深度学习模型最终测试AUC为0.796,热图展示其决策依据
临床怎么用
- 可在度普利尤单抗治疗第4周用RCM观察面部皮损特征,辅助早期识别可能无应答者
局限性
- 队列样本量相对较小
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-invasive prediction of the efficacy of dupilumab on facial lesions in patients with atopic dermatitis (AD) was unresolved. OBJECTIVE: To explore reflectance confocal microscopy (RCM), a non-invasive method, for predicting dupilumab efficacy in treating facial AD lesions and to achieve effective prediction via deep learning. METHODS: Fifty-two AD patients received dupilumab treatment between May 2023 and June 2025 were enrolled. Patients were categorized into 'responder' and 'non-responder' groups based on whether they achieved 75% improvement from baseline in Eczema Area and Severity Index at week 16. RCM was utilized to evaluate facial lesions. Deep learning was employed to construct a prediction model for identifying intergroup differences. RESULTS: Dermal papillary dilation (area under the curve = 0.83, P < .001) and tortuous papillary capillary dilation (area under the curve = 0.81, P < .001) at week 4 correlated significantly with therapeutic non-response. The ResNet101-based deep learning model, trained on patients' RCM images of week 4 post-treatment scans, had a final test area under the curve of 0.796, with heatmaps illustrating its decision-making basis. LIMITATIONS: The cohort size is relatively small. CONCLUSION: Early post-treatment RCM features can effectively predict the efficacy of dupilumab in facial AD lesions combined with deep learning.
引用
- Wan L, Hu Y, Chang JW, et al. Non-invasive prediction of dupilumab response in facial atopic dermatitis using early post-treatment reflectance confocal microscopy features. J Am Acad Dermatol. 2026. PMID: 42556736. doi:10.1016/j.jaad.2026.07.109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。